Interventionhealth facilities N = 637 | Controlhealth facilities N = 330 | Risk ratio(accounting for clustering) | ||||
---|---|---|---|---|---|---|
n* | % (95% CI) | n* | % (95% CI) | Risk ratio (95% CI) | p-value | |
Effect of mRDT implementation on anti-malarial treatment | ||||||
Patients treated with anti-malarials: | ||||||
All patients | 618 | 22% (19-25) | 318 | 60% (54-65) | 0.30 (0.14 - 0.70) | 0.007 |
Patients complaining of fever | 473 | 26% (22-30) | 253 | 65% (59-71) | 0.31 (0.16 - 0.67) | 0.004 |
Patients not complaining of fever | 145 | 9% (4-14) | 65 | 38% (26-51) | 0.23 (0.10 - 0.55) | 0.001 |
Effect of mRDT implementation on adherence to malaria test result | ||||||
Patients treated with anti-malarials: | ||||||
Patients with a positive malaria test | 96 | 100% (100-100) | 155 | 100% (100-100) | 1 | N.A |
Patients with a negative malaria test | 412 | 7% (5-10) | 128 | 25% (17-33) | 0.09 (0.01 - 0.79) | 0.03 |
Effect of mRDT implementation on selection for malaria testing | ||||||
Patients tested for malaria: | ||||||
All patients | 637 | 82% (79-85) | 330 | 89% (86-92) | 0.93 (0.86 - 1.04) | 0.2 |
Patients complaining of fever | 487 | 90% (88-93) | 263 | 95% (93-98) | 0.95 (0.91 - 0.99) | 0.03 |
Patients not complaining of fever | 150 | 57% (49-65) | 67 | 64% (52-76) | 0.91 (0.69 - 1.26) | 0.5 |
Effect of mRDT implementation on antibiotic treatment | ||||||
Patients treated with antibiotics: | ||||||
All patients | 618 | 71% (67-74) | 318 | 53% (48-59) | 1.34 (1.08 - 1.70) | 0.006 |
Patients complaining of fever | 473 | 71% (67-76) | 253 | 52% (46-58) | 1.44 (1.09 - 1.94) | 0.008 |
Patients not complaining of fever | 145 | 68% (61-76) | 65 | 58% (46-71) | 1.17 (0.94 - 1.49) | 0.2 |
Patients with a positive malaria test | 96 | 32% (23-42) | 155 | 28% (21-36) | 1.14 (0.77 - 1.66) | 0.5 |
Patients with a negative malaria test | 412 | 77% (73-81) | 128 | 74% (67-82) | 1.05 (0.91 - 1.26) | 0.5 |
Effect of mRDT implementation on other laboratory tests than malaria | ||||||
Patient tested for urine infection | 637 | 9% (7-11) | 330 | 11% (8-15) | 0.73 (0.34 - 1.58) | 0.4 |
Patient tested for typhoid (Widal) | 637 | 2% (1-3) | 330 | 8% (5-11) | 0.29 (0.04 - 1.97) | 0.2 |
Patient tested for stool parasites | 637 | 7% (5-9) | 330 | 5% (3-8) | 1.27 (0.50 - 3.29) | 0.6 |